Advertisement
Screener

AGAPE ATP CORPORATION (ATPC) Revenue

AGAPE ATP CORPORATION Revenue

AGAPE ATP CORPORATION (ATPC) reported Revenue of $109.10 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Revenue

us-gaap:Revenues · last filed 2026-08-14

  • AGAPE ATP CORPORATION revenues for the quarter ending 2026-06-30 was $109.10K, a 76.56% decline year-over-year.
  • AGAPE ATP CORPORATION revenues for the quarter ending 2026-03-31 was $273.66K, a 5.32% decline year-over-year.
  • AGAPE ATP CORPORATION revenues for the quarter ending 2025-12-31 was $399.13K, a 10.94% increase year-over-year.
  • AGAPE ATP CORPORATION revenues for the quarter ending 2025-09-30 was $370.59K, a 11.86% increase year-over-year.
  • AGAPE ATP CORPORATION revenues for fiscal 2025 was $1.52M, a 15.23% increase from fiscal 2024.
  • AGAPE ATP CORPORATION revenues for fiscal 2024 was $1.32M, a 7.57% decline from fiscal 2023.
  • AGAPE ATP CORPORATION revenues for fiscal 2023 was $1.43M, a 22.92% decline from fiscal 2022.
  • AGAPE ATP CORPORATION revenues for fiscal 2022 was $1.86M, a 82.56% increase from fiscal 2021.
Period endRevenues 3 monthRevenues 3 month as first filedRevenues 6 monthRevenues 9 monthRevenues 12 month
2026-06-30$109.10K
10-Q · filed 2026-08-14
$382.75K
10-Q · filed 2026-08-14
$781.89K
derived: sum of 3 quarters · filed 2026-08-14
$1.15M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$273.66K
10-Q · filed 2026-05-15
$672.79K
derived: sum of 2 quarters · filed 2026-05-15
$1.04M
derived: sum of 3 quarters · filed 2026-05-15
$1.51M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$399.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13
$769.73K
derived: sum of 2 quarters · filed 2026-04-13
$1.24M
derived: sum of 3 quarters · filed 2026-08-14
$1.52M
10-K · filed 2026-04-13
2025-09-30$370.59K
10-Q · filed 2025-11-13
$836.09K
derived: sum of 2 quarters · filed 2026-08-14
$1.13M
10-Q · filed 2025-11-13
$1.48M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$465.50K
10-Q · filed 2026-08-14
$754.54K
10-Q · filed 2026-08-14
$1.11M
derived: sum of 3 quarters · filed 2026-08-14
$1.45M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$289.04K
10-Q · filed 2026-05-15
$648.81K
derived: sum of 2 quarters · filed 2026-05-15
$980.10K
derived: sum of 3 quarters · filed 2026-05-15
$1.29M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$359.78K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13
$691.07K
derived: sum of 2 quarters · filed 2026-04-13
$1.00M
derived: sum of 3 quarters · filed 2026-04-13
$1.32M
10-K · filed 2026-04-13
2024-09-30$331.29K
10-Q · filed 2025-11-13
$644.33K
derived: sum of 2 quarters · filed 2025-11-13
$962.97K
10-Q · filed 2025-11-13
$1.35M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$313.04K
10-Q · filed 2025-08-13
$631.68K
10-Q · filed 2025-08-13
$1.02M
derived: sum of 3 quarters · filed 2025-08-13
$1.38M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$318.64K
10-Q · filed 2025-05-15
$709.71K
derived: sum of 2 quarters · filed 2025-05-15
$1.07M
derived: sum of 3 quarters · filed 2025-05-15
$1.37M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$391.07K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$746.38K
derived: sum of 2 quarters · filed 2025-03-31
$1.05M
derived: sum of 3 quarters · filed 2025-03-31
$1.43M
10-K · filed 2025-03-31
2023-09-30$355.31K
10-Q · filed 2024-11-14
$659.25K
derived: sum of 2 quarters · filed 2024-11-14
$1.04M
10-Q · filed 2024-11-14
$1.43M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$303.94K
10-Q · filed 2024-08-14
$684.70K
10-Q · filed 2024-08-14
$1.07M
derived: sum of 3 quarters · filed 2024-08-14
$1.74M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$380.77K
10-Q · filed 2024-05-14
$767.77K
derived: sum of 2 quarters · filed 2024-05-14
$1.43M
derived: sum of 3 quarters · filed 2024-05-14
$1.83M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$387.01K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$1.05M
derived: sum of 2 quarters · filed 2024-04-01
$1.45M
derived: sum of 3 quarters · filed 2024-04-01
$1.86M
10-K · filed 2024-04-01
2022-09-30$663.89K
10-Q · filed 2023-11-14
$1.06M
derived: sum of 2 quarters · filed 2023-11-14
$1.47M
10-Q · filed 2023-11-14
$1.68M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$396.71K
10-Q · filed 2023-08-14
$805.67K
10-Q · filed 2023-08-14
$1.02M
derived: sum of 3 quarters · filed 2023-08-14
$1.22M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$408.96K
10-Q · filed 2023-05-15
$619.07K
derived: sum of 2 quarters · filed 2023-05-15
$820.36K
derived: sum of 3 quarters · filed 2023-05-15
$1.12M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$210.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$411.40K
derived: sum of 2 quarters · filed 2023-03-31
$715.18K
derived: sum of 3 quarters · filed 2023-03-31
$1.02M
10-K · filed 2023-03-31
2021-09-30$201.28K
10-Q · filed 2022-11-14
$505.07K
derived: sum of 2 quarters · filed 2022-11-14
$806.85K
10-Q · filed 2022-11-14
$1.32M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$303.79K
10-Q · filed 2022-08-11
$605.57K
10-Q · filed 2022-08-11
$1.12M
derived: sum of 3 quarters · filed 2022-08-11
$2.53M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$301.78K
10-Q · filed 2022-05-13
$296.69K
10-Q · filed 2021-05-17
$817.48K
derived: sum of 2 quarters · filed 2022-07-05
$2.23M
derived: sum of 3 quarters · filed 2022-07-05
$3.75M
derived: sum of 4 quarters · filed 2022-07-05
2020-12-31$515.70K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05
$1.93M
derived: sum of 2 quarters · filed 2022-07-05
$3.45M
derived: sum of 3 quarters · filed 2022-07-05
$3.45M
10-K/A · filed 2022-07-05
2020-09-30$1.41M
10-Q/A · filed 2022-07-05
$2.94M
derived: sum of 2 quarters · filed 2022-07-05
$2.94M
10-Q/A · filed 2022-07-05
2020-06-30$1.52M
10-Q · filed 2021-08-13
$1.52M
10-Q · filed 2021-08-13
2019-12-31$192.63K
derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-31
$429.36K
10-K · filed 2021-03-31
$825.83K
derived: sum of 3 quarters · filed 2021-03-31
$1.29M
10-K · filed 2021-03-31
2019-09-30$236.74K
10-Q · filed 2020-11-16
$633.21K
derived: sum of 2 quarters · filed 2020-11-16
$1.10M
10-Q · filed 2020-11-16
$1.37M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$396.47K
10-Q · filed 2020-08-13
$860.77K
10-Q · filed 2020-08-13
$1.13M
derived: sum of 3 quarters · filed 2020-08-13
$1.55M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$464.30K
10-Q · filed 2019-05-13
$734.22K
derived: sum of 2 quarters · filed 2019-05-13
$1.15M
10-Q · filed 2019-05-13
$1.15M
derived: sum of 4 quarters · filed 2019-05-13
2018-12-31$269.92K
10-Q · filed 2019-02-15
$685.29K
10-Q · filed 2019-02-15
$684.67K
derived: sum of 3 quarters · filed 2019-02-15
$682.79K
derived: sum of 4 quarters · filed 2019-05-13
2018-09-30$415.37K
10-Q · filed 2018-11-13
$414.75K
derived: sum of 2 quarters · filed 2018-11-13
$412.87K
derived: sum of 3 quarters · filed 2019-05-13
$412.25K
derived: sum of 4 quarters · filed 2019-05-13
2018-06-30-$621.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-27
-$2.49K
derived: sum of 2 quarters · filed 2019-05-13
-$3.12K
derived: sum of 3 quarters · filed 2019-05-13
$487.00K
10-K · filed 2018-09-27
2018-03-31-$1.87K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-13
-$2.50K
derived: sum of 2 quarters · filed 2019-05-13
$487.63K
10-Q · filed 2019-05-13
2017-12-31-$627.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-15
$489.50K
10-Q · filed 2019-02-15
2017-09-30$490.13K
10-Q · filed 2018-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
VSEE HEALTH, INC. (VSEE)United States$0.003B
DocGo Inc. (DCGO)United States$0.034B-0.25
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Omada Health, Inc. (OMDA)United States$1.207B309.08
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86